Literature DB >> 18820120

Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil.

B C Creagh-Brown1, A G Nicholson, R Showkathali, J S R Gibbs, L S G E Howard.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a disorder which causes progressive pulmonary hypertension, usually presenting with worsening dyspnoea and right heart failure. Pulmonary oedema induced by pulmonary vasodilator therapy to reduce pulmonary arterial pressure has been well described in PVOD, but here we describe a case of PVOD presenting with recurrent episodes of acute non-cardiogenic pulmonary oedema, in the absence of significant pulmonary hypertension. Concern over the risk of precipitating pulmonary oedema led us to use inhaled nitric oxide to predict the safety and efficacy of sildenafil.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820120     DOI: 10.1136/thx.2007.088831

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

2.  Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease.

Authors:  Heidi Lederer; Bettina Muggli; Rudolf Speich; Ula Treder; Hans Stricker; Jeroen Goede; Silvia Ulrich; Simon F Stämpfli; Alexander Breitenstein
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

3.  Upfront triple combination therapy-induced pulmonary edema in a case of pulmonary arterial hypertension associated with Sjogren's syndrome.

Authors:  Kimikazu Takeuchi; Kazuhiko Nakayama; Mitsumasa Okano; Naoki Tamada; Hideya Suehiro; Yuto Shinkura; Kenichi Yanaka; Hiroyuki Onishi; Hidekazu Tanaka; Toshiro Shinke; Noriaki Emoto; Ken-Ichi Hirata
Journal:  Respir Med Case Rep       Date:  2017-12-07

4.  Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.

Authors:  Li Zhang; Yao Wang; Ruifeng Zhang
Journal:  Medicine (Baltimore)       Date:  2021-10-15       Impact factor: 1.889

5.  Hemodynamic rounds: Dilemma in the management of disconnected pulmonary arteries with double arterial ducts.

Authors:  Kothandam Sivakumar; Ashish Ranjan Mohakud
Journal:  Ann Pediatr Cardiol       Date:  2021-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.